Prolactinomas, An interdisciplinary approach : : Proceedings of the International Symposium on Prolactinomas Graz (Austria), April 29 – May 2, 1984 / / ed. by Georg Leb, Gerhard Tscherne, Gerhard F. Walter, Ludwig M. Auer, Wolfgang Urdl.
Saved in:
Table of Contents:
- Frontmatter
- Preface
- Contents
- I. Morphology
- Structure and ultrastructure of prolactinomas
- Prolactinomas and mixed adenomas with prolactin cells: an immunohistochemical study of the subcellular localization of hormones
- Immunocytochemical, chemical and nuclear-DNA studies of pituitary tumours
- Hyperplasia of prolactin pituitary cells with or with out microadenoma
- Hormone-secretion in cell culture of microprolacti nomas, periadenomatous tissue and capsules
- Immunocytochemical, ultrastructural and culture characteristics of prolactin-secreting pituitary adenomas
- Immunohìstochemical hormone determinations in pituitary adenomas in comparison with endocrinological findings in vivo
- New immunocytochemical observations in prolactinomas
- Problematic divergencies between clinical and immunocytochemical findings in prolactinomas
- Necrosis of prolactinoma cells after bromocriptine treatment
- Spontaneous pituitary lesions and plasma prolactin levels in rats
- II. Radiology
- CT-findings in pituitary adenomas
- Comparative study of normal subjects and cases with microadenoma on high-resolution computed tomography
- III. Endocrinological and clinical aspects
- Actions of dopamine receptor agonists at the pituitary level
- Dopamine and prolactinomas
- Rhythmometric study of the circadian profile of plasma prolactin in patients with prolactinoma or empty sella syndrome
- Prolactin responses to thyrotropin-releasing hormone, metoclopramide and insulin-induced hypoglycaemia in hyperprolactinaemic and normoprolactinaemic patients
- Evidence for functional impairment of growth hormone secretion in prolactinoma
- TSH response to dopamine receptor blockade in women with PRL-secreting microadenoma: Long effect of surgical removal
- Prolactin and TSH responses to TRH and domperidone in delayed puberty
- Anterior pituitary function in patients with prolactinomas
- Pituitary adenomas with hyperprolactinaemia in males
- Prolactinoma in multiple endocrine neoplasia type I
- Recurrence of hyperprolactinaemia detected in long-term follow-up of surgically normalized microprolactinomas
- Impairment of pituitary hormone secretion in patients with prolactinoma
- IV. Surgical treatment
- The recurrence of pituitary adenoma — a management challenge
- Transsphenoidal operations for prolactinomas
- Prolactinomas: surgical results in 96 cases
- Effect of transsphenoidal surgery on pituitary function
- Transsphenoidal microsurgical treatment of 77 prolactinomas
- Review of 56 prolactin-secreting pituitary adenomas
- The effect of transsphenoidal selective microadenomectomy on patients with prolactinomas
- Surgical results and long-term follow-up in female and male prolactinomas
- Otoliquorrhoea in large prolactinomas. Pathomechanism and surgical management
- Invasive prolactinomas in adolescents
- Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas
- Long-term follow-up of prolactinomas. Clinical and morphologic correlation
- Clinicopathologîcal and neurosurgical comparative analysis of operated recurrent prolactinomas and non-secreting chromophobe pituitary adenomas
- V. Pharmacotherapy
- New aspects of medical treatment of prolactinomas
- Conservative management of prolactinoma
- Effect of bromocriptine therapy on large prolactinomas
- Macroprolactinomas in male patients: efficiency of treatment with a new dopaminergic drug (CU 32-085-Sandoz), tumour calcification and relative significance of preoperative tumour volume regression as estimated by CT-scan
- Evidence for spontaneous tumour shrinkage in a 45-year-old patient with a 20-year history of untreated microprolactinoma
- The influence of various forms of treatment on serum levels of prolactin, growth hormone and insulin-like growth factors I and II in patients with hyperprolactinaemia and acromegaly
- Persisting partial suppression of growth hormone excess in acromegaly after long term treatment with bromocriptine
- Medical and surgical treatment of micro and macroprolactinomas: seven years follow-up of 65 cases
- VI. Aspects of gynecology and obstetrics
- Management of prolactinomas in pregnancy
- Long-term follow-up of hyperprolactinaemia in women
- Prophylactic bromocriptine treatment during pregnancy of women with macroprolactinomas: report of thirteen pregnancies
- Natural regression after pregnancy of a CT visualized microprolactinoma
- Prolactin levels and ovarian function after surgical treatment of prolactinomas
- Pregnancies after treatment of prolactinomas: course and complications
- Psychosomatic findings in patients with elevated prolactin
- List of contributors
- Authors' index
- Subject index
Similar Items
-
Prolactinomas, prolactin and weight gain / Erika C.O. Naliato.
by: Naliato, Erika C. O.
Published: (c2010.) -
Intraocular Tumors : : International Symposium under the auspices of the European Ophthalmological Society Schwerin, May 17–20, 1981 / / hrsg. von F. C. Blodi, P. K. Lommatzsch.
Published: ([2022]) -
Laryngeal cancer : : an interdisciplinary resource for practitioners / / editors, Jennifer Campion Friberg and Lisa A. Vinney.
Published: (2017.) -
Multidisciplinary Approach for Colorectal Cancer / / edited by Keun-Yeong Jeong.
Published: ([2019]) -
Current approaches to endometrial cancer / / editors, Noriaki Sakuragi, Steven G. Silverberg.
Published: (2014.)